Design of Liposomal Lidocaine/Cannabidiol Fixed Combinations for Local Neuropathic Pain Treatment
The administration of drug fixed combinations by nanocarriers is a new attractive approach since it can allow improvements in both the skin penetration of cargo compounds and their synergistic effects. The cutaneous administration of lidocaine (LD) and cannabidiol (CBD) combination can be useful for...
Main Authors: | Silvia Franzè, Liliana Angelo, Antonella Casiraghi, Paola Minghetti, Francesco Cilurzo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/9/1915 |
Similar Items
-
Preparation and Optimization of an Ultraflexible Liposomal Gel for Lidocaine Transdermal Delivery
by: Mengwei Sun, et al.
Published: (2022-07-01) -
Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis
by: Yael Shilo-Benjamini, et al.
Published: (2023-08-01) -
Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
by: Antonella Casiraghi, et al.
Published: (2020-10-01) -
Effect of intrathecal Bupivacaine–Lidocaine combination on motor block and analgesia period
by: Sara El-Adawy, et al.
Published: (2012-06-01) -
Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration
by: Doo AR, et al.
Published: (2018-03-01)